Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

Apr 23, 2021

New Delhi [India], April 23 : The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin'...

DGCI approves emergency use of Zydus's Virafin in treating moderate COVID-19 infection

Apr 23, 2021

New Delhi [India], April 23 : Zydus Cadila received emergency use approval from the Drugs Controller General of India (DGCI) on Friday for the...

Zydus gets Mexican regulator nod to conduct clinical trials with Pegylated Interferon alpha-2b to treat COVID-19

Jul 17, 2020

Ahmedabad (Gujarat) [India], July 17 : Pharmaceutical major Zydus said on Friday it has got approval from Mexico's Federal Commission for the Protection against...

Zydus Cadila approaches DCGI to use hepatitis drug for COVID-19 clinical trial

May 05, 2020

New Delhi [India], May 5 : The country's top drug regulator, Drug Controller General of India (DCGI), has received an application from Zydus Cadila,...

Four drugs for COVID-19 appear to have little or no effect on reducing mortality: Solidarity trial results

Oct 17, 2020

New Delhi [India], October 17 : The interim analysis of WHO's Solidarity Trial has revealed that 4 repurposed drugs for COVID-19--remdesivir, hydroxychloroquine, lopinavir/ritonavir and...

Four repurposed drugs have no effect on reducing mortality in COVID-19 cases: WHO

Oct 16, 2020

New Delhi [India], October 16 : The interim analysis of World Health Organisation (WHO)'s Solidarity Trial has revealed that four repurposed drugs for COVID-19--remdesivir,...